Onkologie. 2013:7(4):172-175

Colorectal cancer classification

Miroslav Zavoral, Gabriela Vojtěchová, Štěpán Suchánek
Interní klinika, 1. lékařská fakulta Univerzity Karlovy, Ústřední vojenská nemocnice &ndash, Vojenská fakultní nemocnice Praha

Unified and accurate colorectal cancer (CRC) classification is very useful for identification individuals with higher risk of this malignant

disease. It is important for optimal primary and secondary CRC prevention settings. The assessment of the macroscopic appearance

of colorectal lesions duo to the Paris and Kudo classification makes the histological characteristic prediction easier. The knowledge of

histology type, grading and staging of colorectal cancer is the main prerequisite for successful treatment.

Keywords: colorectal cancer, malignant polyp, classification, management

Published: October 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zavoral M, Vojtěchová G, Suchánek Š. Colorectal cancer classification. Onkologie. 2013;7(4):172-175.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Peltomaki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study-The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 1997; 113: 1146-1158. Go to original source... Go to PubMed...
    2. Miyaki M, Konishi M, Tanaka K, et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 1997; 17: 271-272. Go to original source... Go to PubMed...
    3. Plevová P, Novotný J, Šachová M, Křepelová A, Foretová L. Hereditární nepolypózní kolorektální karcinom (HNPCC, Lynchův syndrom). Klin Onkol 2009; 22(Suppl): S12-S15.
    4. Randall WB, et al. NCCN Clinical Practice Guidelines in Oncology. Colorectal Cancer Screening, Version 2. 2012.
    5. Vasen HF, Watson P, Mecklin JP, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116: 1453-1456. Go to original source... Go to PubMed...
    6. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004; 96(4): 261-268. Go to original source... Go to PubMed...
    7. Bülow S, Björk J, Christensen IJ, et al. Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004; 53(3), pp. 381-386. Go to original source... Go to PubMed...
    8. Jasperson KW, Tuohy TM, Neklason DW, et al. Hereditary and familiar colon cancer. Gastroenterology 2010; 138: 2044-2058. Go to original source... Go to PubMed...
    9. Lubbe SJ, Di Bernardo MC, Chandler IP, et al. Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol 2009; 27(24): 3975-3980. Go to original source... Go to PubMed...
    10. Tomlinson IPM, Houston RS. Peutz-Jeghers syndrome. J Med Genet 1997; 34: 1007-1011. Go to original source... Go to PubMed...
    11. Dixon MF, Gastrointestinal epithelial neoplasia: Vienna revisited, Gut, 2002; 51(1): 130-131. Go to original source... Go to PubMed...
    12. Quirke P, Risio M, Lambert R, et al. Quality assurance in pathology in colorectal cancer screening and diagnosis In Segnan N, Patnick J, Von Karsa L. European guidelines for quality assurance in colorectal cancer screening and diagnosis, 1st ed., European Union, 2010: 206-232. Go to original source... Go to PubMed...
    13. Kudo S, Tamura S, Nakajima T, et al. Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc 1996; 44: 8-14. Go to original source... Go to PubMed...
    14. Rejchrt S. Gastrointestinal epithelial neoplasia. We can see only what we already know. Folia Gastroenterol Hepatol 2004; 2: 143-146.
    15. Robertson DJ, Greenberg ER, Beach M, et al. Colorectal cancer in patients under close colonoscopic surveillance, Gastroenterology, 2005; 129(1): 34-41. Go to original source... Go to PubMed...
    16. Martinez ME, Baron JA, Lieberman DA, et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy, Gastroenterology, 2009; 136(3): 832-841. Go to original source... Go to PubMed...
    17. ASGE guideline: the role of endoscopy in the diagnosis, staging, and management of colorectal cancer. Gastrointestinal Endoscopy. 2005; 61(1). Go to original source... Go to PubMed...
    18. Nascimbeni R, Burgart LJ, Nivatvongs, et al. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum, Dis.Colon Rectum, 45(2) 200-206.
    19. Hamilton SR, Rubio CA, Vogelstein B, et al. Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA, editors. Health Organization classification of tumours. Tumours of the digestive system. Lyon, France: IARC Press; 2000. p. 101-119.
    20. Sobin LH, Gospodarowicz MK, Wittekind C, at al. TNM Classification of Malignant Tumours, 7th edition, 2009. Wiley-Blackwell. Go to original source...
    21. Benson B, Arnoletti JP, Bekaii-Saab T, et al. National Comprehensive Cancer Network Guidelines Version 2. 2012, 2011.
    22. Amado RG, Wolf M, Peeters M, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol. 2008; 26(10): 1626-1634. Go to original source... Go to PubMed...
    23. Van Cutsem E, Köhne CH, Hitre E, Zaluski J, et al.Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009; 360(14): 1408-1417. Go to original source... Go to PubMed...
    24. Di Nicolantonio F, Martini M, Molinari F, Sartore-Bianchi A, et al.Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. J Clin Oncol. 2008; 26(35): 5705-5712. Go to original source... Go to PubMed...
    25. Vyzula R, et al. Modrá kniha České onkologické společnosti. Masarykův onkologický ústav; 2013. 59-75.

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.